Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 37,164 | 18,193 | 12,029 | 15,165 | 18,050 |
| Gross Profit | 37,164 | 18,193 | 12,029 | 15,165 | 18,050 |
| Operating Expenses | 29,123 | 27,780 | 26,208 | 25,844 | 28,821 |
| Operating Income | 8,041 | -9,586 | -14,179 | -10,680 | -10,769 |
| Interest Expense | 10,912 | 19,695 | 10,246 | -13,576 | 15,408 |
| Other Income | 3,460 | 5,545 | 6,298 | 3,541 | 3,062 |
| Pre-tax Income | 589 | -23,736 | -18,127 | 6,437 | -23,115 |
| Income Tax | N/A | N/A | N/A | N/A | -59 |
| Net Income Continuous | 589 | -23,736 | -18,127 | 5,923 | -23,056 |
| Net Income | $589 | $-23,736 | $-18,128 | $5,922 | $-23,056 |
| EPS Basic Total Ops | 0.01 | -0.24 | -0.18 | 0.02 | -0.23 |
| EPS Basic Continuous Ops | 0.01 | -0.24 | -0.18 | 0.03 | -0.23 |
| EPS Diluted Total Ops | 0.01 | -0.24 | -0.18 | 0.25 | -0.23 |
| EPS Diluted Continuous Ops | 0.01 | -0.24 | -0.18 | 0.05 | -0.23 |
| EPS Diluted Before Non-Recurring Items | 0.01 | -0.24 | -0.18 | -0.16 | -0.23 |
| EBITDA(a) | $13,052 | $-4,570 | $-9,248 | $-4,850 | $-6,051 |